Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Tapentadol IR for Acute Pain from Bunionectomy
NCT00613938Phase 3Completed
- Sponsor
- Johnson & Johnson
- Start
- Feb 2008
- Primary completion
- Oct 2008
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of tapentadol in acute pain, sponsored by Johnson & Johnson. Started Feb 2008; status: completed.
02
Drugs
tapentadol
03
Conditions
acute pain
Beyond the preview
Go deeper on NCT00613938.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00613938.